Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)


Charts by TradingView

Pricing is indicative. Past performance is not a reliable indicator of future results. Log in to see latest markets data.

Regeneron Pharmaceuticals (REGN) Profile

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York, about 25 miles north of Midtown Manhattan.

Number of employees 9,123 (2020) Total assets US$17.163 billion (2020) Market cap 67.26 B USD

Regeneron Pharmaceuticals (REGN.xnas))News TARRYTOWN, N.Y., Dec. 22, 2021 /PRNewswire/ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast its presentation at the 40th Annual J.P. Morgan Healthcare Conference on Monday, January 10, 2022. The presentation is scheduled for 10:30 a.m. Eastern Time and may be accessed from the "Investors & Media" page of Regeneron's website

Subsidiaries Rockwood Road Holdings LLC, Regeneron Assurance Inc., Loop Road Holdings LLC, Regeneron Healthcare Solutions Inc.

Regeneron Pharmaceuticals (REGN.xnas))News Dec 23 (Reuters) - The U.S. government has paused the distribution of COVID-19 antibody treatments from Regeneron Pharmaceuticals REGN.O and Eli Lilly LLY.N, saying the therapies were unlikely to be effective against the Omicron coronavirus variant.The variant has become the dominant strain in the United States with lightning speed, resurrecting restrictions and stretching the country's testing infrastructure.

Regeneron Pharmaceuticals (REGN.xnas) Analysis Regeneron has leveraged its monoclonal antibody research and development platform to become one of the few biotechs to successfully emerge as a profitable commercial operation

Holding cost
Long
-5%
Short
-2.5%
Trading hours in US Eastern Time
Fri
10:00 - 18:30
Mon
10:00 - 18:30
Tue
10:00 - 18:30
Wed
10:00 - 18:30
Thu
10:00 - 18:30
Sun
Closed
Sat
Closed

Start Trading Regeneron Pharmaceuticals (REGN)
with a Market Leader Today

Share CFD Trading FAQ

Each investor owning shares of a company is also owning fragments of the company. A quite simple way to explain what a stock is is basically when a company divides itself into several shares and then it makes a part of these equities available to the public, at a price. Each investor owning shares of a company is owning fragments of the company.

While shares represent units of ownership within a company Contracts for Difference (CFDs) allow traders to speculate on the future share price fluctuations of an underlying asset. Thus when trading CFDs traders do not physically own the underlying asset. CFDs are available for a range of underlying assets, such as shares, commodities, and foreign exchange, and indices.

6 Reasons to Trade Share
CFDs with FP Markets

An Australian-regulated
forex & CFD broker

Go Long or Short

Increase your ability to profit in all market conditions Leverage options up to 20:1

Direct Market Access (DMA) Execution

Real-time, transparent share prices Control, Functionality and deep liquidity Full Market depth & see your orders in the queue

Advanced Platforms
& Technology

MT4, MT5, Webtrader & Iress with superior client portal

24/5 Multilingual
Customer Support

Award winning support & personal account managers

Global Exposure

Low margins and competitive commission +10,000 products on global stocks across 4 continents

Earn Dividends

On long positions No ownership of physical shares necessary

Start Trading
in Minutes

Open an account now

bullet Access 10,000+ financial instruments
bullet Auto open & close positions
bullet News & economic calendar
bullet Technical indicators & charts
bullet Many more tools included

By supplying your email you agree to FP Markets privacy policy and receive future marketing materials from FP Markets. You can unsubscribe at any time.





Get instant Updates in Telegram
Sitemap | © FP Markets 2022